Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Roivant Sciences Ltd. (ROIV) had Normalized Income after Taxes of $387.28M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$2.52M |
|
$302.99M |
|
$0.32M |
|
$2.20M |
|
$-412.72M |
|
$415.24M |
|
$38.86M |
|
$454.10M |
|
$480.02M |
|
$355.74M |
|
$355.74M |
|
$355.74M |
|
|
Normalized Income after Taxes |
$387.28M |
$415.24M |
|
-- |
|
702.13M |
|
812.29M |
|
$0.43 |
|
$0.28 |
|
| Balance Sheet Financials | |
$5.06B |
|
-- |
|
-- |
|
$5.71B |
|
-- |
|
-- |
|
-- |
|
$416.27M |
|
-- |
|
$5.29B |
|
$5.29B |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|